Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Clinical Data
Biotech
Compass tracks PTSD improvements in midphase psilocybin trial
Compass linked its psilocybin therapy and psychological support to improvements in post-traumatic stress disorder in a small study.
Nick Paul Taylor
May 8, 2024 8:07am
Regeneron's 'protein factory' gene therapy restores hearing
May 8, 2024 6:00am
Calliditas' cancer trial misses primary goal, hits on survival
May 7, 2024 6:39am
GlycoMimetics fails phase 3 blood cancer trial, sinking stock
May 6, 2024 8:11am
CG sets new bar in bladder cancer, months after huge IPO
May 3, 2024 11:23am
Jacobio's KRAS data tee up safety-focused lung cancer pitch
May 1, 2024 7:01am